In severe folate deficiency, bone marrow often becomes very active but cannot make healthy blood cells efficiently. It contains unusually large, immature red blood cell precursors called megaloblasts, and other blood-cell precursors may also look abnormal. Many developing cells die before entering the bloodstream, so blood tests may show anemia and, in more severe cases, low white blood cells or platelets.
Why does severe folate deficiency change the bone marrow?
Folate, also known as vitamin B9, is essential for making DNA, the material cells need to grow and divide. Bone marrow is the soft tissue inside certain bones where red blood cells, white blood cells, and platelets develop. Because these cells are produced continuously, their developing precursors need an adequate supply of folate.
When folate levels are severely reduced, DNA production is impaired and developing blood cells cannot mature normally. The nucleus, which contains the cell's DNA, matures more slowly than the surrounding cytoplasm. This mismatch produces a characteristic pattern called megaloblastic change. When this process leads to anemia, the condition is known as megaloblastic anemia.
What are the main bone marrow findings in severe folate deficiency?
When a bone marrow sample is examined under a microscope, several changes may be seen. Their extent depends on the severity of the deficiency and whether other blood or nutritional problems are present.
- Hypercellular bone marrow: The marrow often contains more blood-forming cells than expected for the person's age. This increased cellularity reflects active but ineffective blood cell production.
- Increased numbers of megaloblasts: Developing red blood cells are unusually large, with immature-looking nuclei and relatively mature cytoplasm. These cells are a defining feature of megaloblastic marrow.
- Nuclear-cytoplasmic asynchrony: The cell's nucleus appears less mature than the cytoplasm around it. In other words, the parts of the cell develop at different rates.
- Abnormal white blood cell precursors: Developing cells in the granulocyte family, which includes neutrophils, may also show abnormal maturation. Particularly large precursors called giant metamyelocytes may be present.
- Ineffective blood cell production: Some developing cells die inside the marrow before they can become functional blood cells and enter the circulation.
A review available through the U.S. National Library of Medicine's PubMed Central describes the combination of increased marrow cellularity, enlarged megaloblastic red blood cell precursors, and abnormalities affecting other blood-forming cell lines in megaloblastic anemia.
What does nuclear-cytoplasmic asynchrony mean?
Normally, a developing blood cell's nucleus and cytoplasm mature in a coordinated way. In megaloblastic anemia, impaired DNA synthesis delays nuclear development, while the cytoplasm continues to mature. The result is an unusually large cell with a nucleus that looks less developed than its surrounding cytoplasm. This microscopic appearance helps pathologists recognize a megaloblastic pattern.
Why can an active bone marrow still produce too few blood cells?
A marrow with increased cellularity may appear highly productive, but the number of cells that successfully reach the bloodstream can remain low. Abnormal maturation causes many developing cells to die within the marrow, a process known as intramedullary cell death. This leads to ineffective hematopoiesis, meaning that blood cell production is active but does not yield enough mature circulating cells.
How do these bone marrow changes affect blood test results?
The marrow findings are often accompanied by changes in a complete blood count (CBC) and a peripheral blood smear, which examines blood cells under a microscope. According to the Merck Manual Professional Edition, megaloblastic anemia commonly produces enlarged red blood cells, variation in cell size and shape, and neutrophils with abnormally segmented nuclei.
Depending on the severity and duration of the deficiency, related findings may include:
- Macrocytic anemia: Red blood cells are larger than usual, often reflected by an increased mean corpuscular volume (MCV) on the CBC.
- Macro-ovalocytes: Red blood cells in the bloodstream appear larger and more oval-shaped than usual.
- Hypersegmented neutrophils: Some white blood cells have nuclei divided into an unusually large number of segments. This is a peripheral blood finding, rather than a specific bone marrow feature.
- A low reticulocyte count: Reticulocytes are newly released red blood cells. Their number may be lower than expected because ineffective production limits the release of new cells.
- Leukopenia or thrombocytopenia: More advanced cases may have reduced white blood cell or platelet counts, respectively. When red blood cells, white blood cells, and platelets are all reduced, the pattern is called pancytopenia.
These abnormalities reflect the effects of impaired maturation on blood cell production. Their presence and extent help clinicians assess the overall pattern, but not every person with folate deficiency will have all of these findings. Other conditions can produce similar blood count changes.
Is a bone marrow biopsy needed to identify severe folate deficiency?
Usually, a bone marrow biopsy is not the first test used to investigate suspected folate deficiency. The initial assessment generally involves a CBC, examination of a peripheral blood smear when appropriate, and blood tests for folate and vitamin B12. According to MedlinePlus, a bone marrow aspiration may be performed in rare cases of folate-deficiency anemia.
A bone marrow aspiration collects a small amount of liquid marrow for microscopic examination. A biopsy collects a small core of marrow tissue. These procedures can provide additional information about how blood cells are developing, but they are not routinely necessary when the blood test results and clinical picture clearly explain the problem.
A clinician may consider a marrow examination when blood count abnormalities remain unexplained, the findings do not fit the expected pattern, or another bone marrow disorder is suspected. The decision depends on the blood results, medical history, medications, examination findings, and how the abnormalities change over time.
Can bone marrow findings distinguish folate deficiency from vitamin B12 deficiency?
No. Folate deficiency and vitamin B12 deficiency can cause very similar megaloblastic changes in the bone marrow. Both interfere with normal DNA synthesis and can lead to enlarged blood cell precursors, abnormal maturation, and ineffective blood cell production. The appearance of the marrow alone generally cannot establish which vitamin is deficient.
The Merck Manual Professional Edition's guidance on folate deficiency notes that the blood count changes associated with folate deficiency can be indistinguishable from those caused by vitamin B12 deficiency. Clinicians therefore assess both vitamin levels rather than relying on the marrow appearance alone.
This distinction is important because vitamin B12 deficiency can cause neurological problems that folate supplementation does not correct. Folate treatment can improve the anemia while a vitamin B12-related neurological problem continues. If megaloblastic changes are identified, the underlying cause should therefore be clarified before treatment decisions are made.
How are the findings interpreted in the wider clinical picture?
Bone marrow morphology is one part of a broader evaluation, not a standalone diagnosis. A clinician may review the CBC, reticulocyte count, peripheral blood smear, folate and vitamin B12 levels, and other tests guided by the circumstances. Certain medications and other disorders that affect blood cell maturation can also produce megaloblastic changes.
When severe folate deficiency is confirmed, the clinical team evaluates why it developed and whether another nutritional deficiency or medical condition is contributing to the blood abnormalities. Persistent or unexplained abnormalities may require further investigation, particularly if the blood cell counts do not fit the expected pattern.
The key finding in severe folate deficiency is usually a megaloblastic pattern of blood cell development: enlarged, abnormally maturing precursors in a marrow that is often hypercellular, combined with ineffective blood cell production. Blood tests and the clinical context are essential for determining whether folate deficiency explains this pattern and whether additional investigation is needed.